OpenAI-FDA Talks Boost AI’s Role in Drug Evaluations

Wednesday, May 7, 2025, 5:20 pm

High-ranking OpenAI officials have been in discussions with FDA representatives about integrating AI into drug evaluation processes. Both accounts reference a project cderGPT, underscoring industry and regulatory momentum towards AI-driven reforms in healthcare, all while navigating cautious optimism and bureaucratic rigor.

Reddit: r/politics

Bluesky: @culturecrave.co, @techcrunch.com


winbuzzer.com / OpenAI & FDA Discuss AI Role in Drug Evaluation

OpenAI is in talks with the US FDA about using AI, potentially via a project called cderGPT, to assist in drug evaluations, aiming to modernize and potentially speed up the lengthy approval process while navigating reliability and regulatory concerns. The post OpenAI & FDA Discuss AI Role in…

techcrunch.com / OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the…

wired.com / OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT.


permalink / 3 stories from sources in 2 days ago #ai #openai #government #pharmaceuticals




More Top Stories...


Google to Pay Billion-Dollar Settlement Over Texas Privacy Claims

Google has agreed to a settlement of roughly $1.375 billion to settle allegations of invasive data tracking practices in Texas. Both reports detail the breach of users’ sensitive geolocation and privacy rights, marking another hefty reminder that digital privacy demands serious oversight—even if enforcement sometimes seems as elusive as a mirage. More...


Apple Shifts iPhone Production to Brazil to Dodge U.S. Tariffs

Facing escalating U.S. tariffs, Apple appears to be quietly shifting iPhone production to Brazil through its Foxconn partnership. Despite Apple’s denials, industry insiders suggest this strategic relocation aims to stabilize prices and secure the supply chain, proving that when it comes to international trade, geography often trumps rhetoric. More...


Samsung Galaxy S25 Edge Reveal Sparks Tech Buzz

Samsung has kicked off a high-profile unveiling of its long-anticipated superslim Galaxy S25 Edge, sparking excitement among tech enthusiasts. The event showcased the phone’s innovative design and cutting-edge features, setting the stage for a fiercely competitive market. Not exactly a revolution, but enough to make followers drool. More...


Rippling Soars to $16.8 Billion Valuation Amid Financing Round

HR tech startup Rippling has astonished investors by reaching a $16.8 billion valuation following a $450 million Series G financing round. This meteoric rise, buoyed by savvy venture capital interest (YC reportedly being one of the backers), adds another chapter to today’s ever-expanding unicorn saga. More...


US border agents to photograph car exiters with facial recognition

U.S. Customs and Border Protection is set to capture every face of drivers leaving the country with high-tech facial recognition that matches travelers against their passports. The agency’s ambitious plan has security officials applauding while privacy advocates raise an eyebrow at this unprecedented surveillance move. More...



Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.